A 52-year-old man with poorly controlled type 2 diabetes mellitus and chronic liver disease presents with fasting blood glucose of 280 mg/dL despite metformin therapy. All of the following mechanisms contribute to hyperglycemia in this patient EXCEPT:

Question

Accepted Answer

B. Impaired hepatic glycogen synthesis due to reduced glucokinase activity. ## Hyperglycemia in Type 2 Diabetes with Liver Disease

**Key Point:** In type 2 diabetes with hepatic dysfunction, hyperglycemia arises primarily from **increased hepatic glucose output** (both gluconeogenesis and glycogenolysis) and **decreased peripheral glucose uptake**, NOT from impaired glycogen synthesis.

### Analysis of Each Mechanism

#### Why Impaired Glycogen Synthesis Is NOT a Primary Cause

Glycogen synthesis requires insulin signaling and adequate glucose availability. Although hepatic insulin resistance reduces glycogen synthesis, this is a **minor contributor** to hyperglycemia. The liver's glycogen stores are finite (~100–120 g), and in the fed state, impaired synthesis would reduce glycogen *storage*, not directly cause hyperglycemia. In fact, the liver compensates by increasing gluconeogenesis and glycogenolysis — the opposite of what happens with impaired synthesis.

**High-Yield:** A common trap — students assume "impaired glycogen synthesis" = "hyperglycemia," but the relationship is indirect. Hyperglycemia in diabetes comes from **excessive glucose production**, not from failure to store glucose.

#### Correct Mechanisms Contributing to Hyperglycemia

| Mechanism | Pathophysiology | Clinical Relevance |
|-----------|-----------------|-------------------|
| **Increased gluconeogenesis** | Hepatic insulin resistance → reduced inhibition of PEPCK and pyruvate carboxylase; increased substrate availability (lactate, amino acids) | Major contributor; worsened by liver disease |
| **Increased glycogenolysis** | Loss of hepatic insulin's inhibitory effect on glycogen phosphorylase; increased counter-regulatory hormone sensitivity | Contributes to fasting hyperglycemia |
| **Decreased muscle glucose uptake** | Insulin resistance at GLUT4 level; reduced glucose transporter translocation | Major contributor; worsens hyperglycemia |
| **Impaired glycogen synthesis** | Reduced insulin signaling; decreased glycogen synthase activity | Minor contributor; does NOT directly cause hyperglycemia |

**Clinical Pearl:** In type 2 diabetes, hepatic glucose output accounts for ~50% of fasting hyperglycemia, while impaired muscle glucose uptake accounts for ~40%. Impaired glycogen synthesis is a consequence of insulin resistance, not a driver of hyperglycemia.

### Pathophysiology Flowchart

```mermaid
flowchart TD
  A[Type 2 Diabetes + Liver Disease]:::outcome --> B[Hepatic Insulin Resistance]:::outcome
  B --> C[Increased Gluconeogenesis]:::action
  B --> D[Increased Glycogenolysis]:::action
  C --> E[↑ Hepatic Glucose Output]:::urgent
  D --> E
  E --> F[Hyperglycemia]:::urgent
  B --> G[Impaired Glycogen Synthesis]:::action
  G --> H[Reduced Glycogen Storage]:::outcome
  H -.->|Minor effect| F
  I[Insulin Resistance in Muscle]:::outcome --> J[Decreased Glucose Uptake]:::action
  J --> F
```

**Mnemonic:** **HGO** — Hyperglycemia in type 2 diabetes is driven by **H**epatic Glucose **O**utput (gluconeogenesis + glycogenolysis) and impaired **G**lucose uptake (muscle), NOT by glycogen synthesis defects.

Answer

A. Enhanced glycogenolysis from hepatic glycogen stores due to increased epinephrine sensitivity

Answer

C. Decreased glucose uptake by skeletal muscle due to insulin resistance

Answer

D. Increased gluconeogenesis from lactate and amino acids due to hepatic insulin resistance

A 52-year-old man with poorly controlled type 2 diabetes mellitus and chronic liver disease presents with fasting blood glucose of 280 mg/dL despite metformin therapy. All of the following mechanisms contribute to hyperglycemia in this patient EXCEPT:

Explanation

Hyperglycemia in Type 2 Diabetes with Liver Disease

Analysis of Each Mechanism

Why Impaired Glycogen Synthesis Is NOT a Primary Cause

Correct Mechanisms Contributing to Hyperglycemia

Pathophysiology Flowchart

Practice similar questions

Join our NEET PG community

Mechanism	Pathophysiology	Clinical Relevance
Increased gluconeogenesis	Hepatic insulin resistance → reduced inhibition of PEPCK and pyruvate carboxylase; increased substrate availability (lactate, amino acids)	Major contributor; worsened by liver disease
Increased glycogenolysis	Loss of hepatic insulin's inhibitory effect on glycogen phosphorylase; increased counter-regulatory hormone sensitivity	Contributes to fasting hyperglycemia
Decreased muscle glucose uptake	Insulin resistance at GLUT4 level; reduced glucose transporter translocation	Major contributor; worsens hyperglycemia
Impaired glycogen synthesis	Reduced insulin signaling; decreased glycogen synthase activity	Minor contributor; does NOT directly cause hyperglycemia